📋 RAPT Therapeutics, Inc. (RAPT) - Clinical Trial Update
Filing Date: 2022-05-31
Accepted: 2022-05-31 16:18:11
Event Type: Clinical Trial Update
Event Details:
RAPT Therapeutics Inc (RAPT) Announces Clinical Trial Update
RAPT Therapeutics Inc (RAPT) provided an update on its clinical development programs.
Clinical Development Highlights:
Drug Program: jurisdiction, needs
Diseases/Conditions: which such offer
Collaboration: RAPT Therapeutics, Inc.
targeting C-C motif chemokine receptor 4 (CCR4), for the treatment of inflammation and cancer, respectively. The company is also pursuing a range of targets that are in the discovery stage of development. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995
📋 RAPT Therapeutics, Inc. (RAPT) - Clinical Trial Update
Filing Date: 2022-05-31
Accepted: 2022-05-31 16:18:11
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
No business developments data available.
Structured Data: